Cargando…

Clinical Validity of Circulating Tumor DNA as Prognostic and Predictive Marker for Personalized Colorectal Cancer Patient Management

SIMPLE SUMMARY: CtDNA analysis is a promising tool in liquid biopsy for the detection of tumor recurrence and progression, and is increasingly adopted into clinical practice. Still, guidelines for the accurate clinical interpretation of ctDNA analysis results are largely lacking, especially for tumo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hallermayr, Ariane, Steinke-Lange, Verena, Vogelsang, Holger, Rentsch, Markus, de Wit, Maike, Haberl, Christopher, Holinski-Feder, Elke, Pickl, Julia M. A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8834623/ https://www.ncbi.nlm.nih.gov/pubmed/35159118 http://dx.doi.org/10.3390/cancers14030851

Ejemplares similares

Somatic copy number alteration and fragmentation analysis in circulating tumor DNA for cancer screening and treatment monitoring in colorectal cancer patients
por: Hallermayr, Ariane, et al.
Publicado: (2022)

Highly sensitive liquid biopsy Duplex sequencing complements tissue biopsy to enhance detection of clinically relevant genetic variants
por: Hallermayr, Ariane, et al.
Publicado: (2022)

Impact of cfDNA Reference Materials on Clinical Performance of Liquid Biopsy NGS Assays
por: Hallermayr, Ariane, et al.
Publicado: (2023)

Extending the critical regions for mutations in the non‐coding gene RNU4ATAC in another patient with Roifman Syndrome
por: Hallermayr, Ariane, et al.
Publicado: (2018)

Overview of the Clinical Features of Li-Fraumeni Syndrome and the Current European ERN GENTURIS Guideline
por: Kratz, Christian Peter, et al.
Publicado: (2021)

Transcript capture and ultradeep long-read RNA sequencing (CAPLRseq) to diagnose HNPCC/Lynch syndrome
por: Schwenk, Vincent, et al.
Publicado: (2023)

Constitutional chromothripsis of the APC locus as a cause of genetic predisposition to colon cancer
por: Scharf, Florentine, et al.
Publicado: (2022)

Diagnostic yield and clinical relevance of expanded germline genetic testing for nearly 7000 suspected HBOC patients
por: Henkel, Jan, et al.
Publicado: (2023)

Cancer risks in Lynch syndrome, Lynch-like syndrome, and familial colorectal cancer type X: a prospective cohort study
por: Bucksch, Karolin, et al.
Publicado: (2020)

Disease-causing gene-flanking genomic rearrangements in HNPCC patients
por: Morak, Monika, et al.
Publicado: (2011)

Splicing analyses for variants in MMR genes: best practice recommendations from the European Mismatch Repair Working Group
por: Morak, Monika, et al.
Publicado: (2022)

Correspondence: Reply to ‘SEMA4A variation and risk of colorectal cancer'
por: Sill, Heinz, et al.
Publicado: (2016)

Polymorphisms of genes coding for ghrelin and its receptor in relation to colorectal cancer risk: a two-step gene-wide case-control study
por: Campa, Daniele, et al.
Publicado: (2010)

Identification of genetic variants for clinical management of familial colorectal tumors
por: Dominguez-Valentin, Mev, et al.
Publicado: (2018)

Initial Clinical Experience with NIPT for Rare Autosomal Aneuploidies and Large Copy Number Variations
por: Harasim, Thomas, et al.
Publicado: (2022)

Primary Mucinous Adenocarcinoma of the Vermiform Appendix with High Grade Microsatellite Instability
por: Komm, Moritz, et al.
Publicado: (2011)

Association Between TAS2R38 Gene Polymorphisms and Colorectal Cancer Risk: A Case-Control Study in Two Independent Populations of Caucasian Origin
por: Carrai, Maura, et al.
Publicado: (2011)

Critical assessment of secondary findings in genes linked to primary arrhythmia syndromes
por: Diebold, Isabel, et al.
Publicado: (2020)

Circulating Inflammatory Mediators as Potential Prognostic Markers of Human Colorectal Cancer
por: Di Caro, Giuseppe, et al.
Publicado: (2016)

TM4SF10 gene sequencing in XLMR patients identifies common polymorphisms but no disease-associated mutation
por: Christophe-Hobertus, Christiane, et al.
Publicado: (2004)

Mitochondrial and nuclear disease panel (Mito‐aND‐Panel): Combined sequencing of mitochondrial and nuclear DNA by a cost‐effective and sensitive NGS‐based method
por: Abicht, Angela, et al.
Publicado: (2018)

Correction: Circulating Inflammatory Mediators as Potential Prognostic Markers of Human Colorectal Cancer
por: Di Caro, Giuseppe, et al.
Publicado: (2016)

Novel RNA Markers in Prostate Cancer: Functional Considerations and Clinical Translation
por: Pickl, Julia M. A., et al.
Publicado: (2014)

HPO-driven virtual gene panel: a new efficient approach in molecular autopsy of sudden unexplained death
por: Schön, Ulrike, et al.
Publicado: (2021)

Circulating Serum miRNAs as Diagnostic Markers for Colorectal Cancer
por: Zekri, Abdel-Rahman N., et al.
Publicado: (2016)

Chemerin Isoforms and Activity in Obesity
por: Buechler, Christa, et al.
Publicado: (2019)

Circulating basophil count as a prognostic marker of tumor aggressiveness and survival outcomes in colorectal cancer
por: Liu, Qi, et al.
Publicado: (2020)

Detection and Clinical Value of Circulating Tumor Cells as an Assisted Prognostic Marker in Colorectal Cancer Patients
por: Pan, Rui-Jun, et al.
Publicado: (2021)

Genomic and Transcriptomic Research in the Discovery and Application of Colorectal Cancer Circulating Markers
por: Ponomaryova, Anastasia A., et al.
Publicado: (2023)

Prognostic value of circulating endothelial cells in metastatic colorectal cancer
por: Rahbari, Nuh N, et al.
Publicado: (2017)

Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as a Liquid Biopsy Marker in Colorectal Cancer
por: Heidrich, Isabel, et al.
Publicado: (2021)

Molecular markers in circulating tumour cells from metastatic colorectal cancer patients
por: Gazzaniga, Paola, et al.
Publicado: (2010)

Circulating tumor DNA as a therapy response marker in metastatic colorectal cancer
por: Ma, Xiaoju Max, et al.
Publicado: (2022)

Respiratory chain deficiency in nonmitochondrial disease
por: Pyle, Angela, et al.
Publicado: (2015)

Clopidogrel and proton pump inhibitor (PPI) interaction: separate intake and a non-omeprazole PPI the solution?
por: Kenngott, S, et al.
Publicado: (2010)

CD26-positive/CD326-negative circulating cancer cells as prognostic markers for colorectal cancer recurrence
por: LIETO, EVA, et al.
Publicado: (2015)

Haplotype analysis suggest that the MLH1 c.2059C > T mutation is a Swedish founder mutation
por: von Salomé, Jenny, et al.
Publicado: (2017)

Prognostic markers for colorectal cancer
por: Tyrrell, Helen E.J., et al.
Publicado: (2018)

Circulating Adipokines and Hepatokines Serve as Diagnostic Markers during Obesity Therapy
por: Schmid, Andreas, et al.
Publicado: (2022)

Hyperintense Acute Reperfusion Marker on FLAIR in Posterior Circulation Infarction
por: Förster, Alex, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_i5uajp2tnjb7ji4ic8spgptosf